Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

2 results

  • Topics : Urinary bladder diseases
  • Active substance : ceftriaxone
Filter
Topic
  • Diagnostic and therapeutic techniques (2)
  • Plus ...
    • Drug therapy (2)
  • Diseases and conditions (2)
  • Plus ...
    • Urologic diseases (2)
    • Plus ...
      • Urinary bladder diseases (2)
    • Infectious diseases (2)
    • Plus ...
      • Bacterial infections (2)
    • Pregnancy and reproduction (1)
    • Plus ...
      • Pregnancy (1)
Content type
  • Practice Guidelines and Other Guides (2)
  • Plus ...
    • Practice guidelines (2)
Date
  • Last three months (2)
Language
  • Français (2)
Active substance
  • acide clavulanique (2)
  • acide fusidique (2)
  • alcool (2)
  • amoxicilline (2)
  • ceftriaxone (2)
  • ciprofloxacine (2)
  • clarithromycine (2)
  • clindamycine (2)
  • doxycycline (2)
  • josamycine (2)
  • mupirocine (2)
  • ofloxacine (2)
  • pristinamycine (2)
  • vaseline (2)
 More filter Other Filter Icon
Search Export

Practice guidelines and other guides - 2 results

  • Acute simple cystitis, cystitis with risk of complication or recurrent cystitis in women

    Practice guidelines - Posted on 27/8/2021 - Mis à jour le 13/5/2025
    Add to my selection

  • Pregnant women - urinary colonisation and cystitis

    Practice guidelines - Posted on 27/8/2021 - Mis à jour le 13/5/2025
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
4XErQ05J3vVQju9h